Business Wire

NY-IMPACTWAYV

9.3.2021 15:02:11 CET | Business Wire | Press release

Share
ImpactWayv™ Completes Beta Test of Its Social Impact Media and Technology Platform and Announces Upcoming Public Launch

ImpactWayv, Inc. is pleased to announce it has recently concluded the private beta test of ImpactWayv ™, the company’s pioneering social impact media and technology networking platform that will launch publicly this spring. ImpactWayv connects people, businesses and philanthropy – for good.

Designed to be a healthier and more meaningful alternative to major social networking platforms, ImpactWayv is the next generation digital ecosystem where people, businesses and nonprofits engage to effect positive change and maximize social impact. ImpactWayv unites disparate sources of information, initiatives and innovations from across the global social good sector under one digital roof to generate greater and more efficient collective impact.

Reception to ImpactWayv’s invitation-only private beta test was overwhelmingly positive, with individual, business and nonprofit users confirming the strong need for this type of holistic social impact-focused platform within today’s social media landscape. Users were guided through ImpactWayv’s core user flow to validate design, functionality and usability. The results reinforced the platform’s underlying social impact thesis, focused on fostering universal social good through a continuous cycle of engagement, interaction and empowerment.

At a time of unprecedented interest in social action globally, ImpactWayv provides the social media network solution that addresses the convergence of three major trends in society:

  • People’s hunger for greater purpose and meaning in all aspects of life – family, friends, social interaction, employment, consumer relationships, investing, donating and volunteering.
  • Businesses’ imperative to demonstrate to all stakeholders and the world their social good efforts.
  • Nonprofits’ pressing need for global connectivity and adoption of private sector business and marketing principles, supporting sustainability and mission achievement.

“ImpactWayv is uniquely positioned for this moment in time,” said George Dolatly, Co-Founder and President of ImpactWayv, Inc. “Our groundbreaking platform creates the opportunity for people, businesses and nonprofits to work together efficiently and effectively on all fronts to maximize social good and positive change.”

ImpactWayv will also feature a digital “Social Impact as a Service” (SIaaS) offering to both businesses and nonprofits to best address emerging social impact trends such as business models that integrate the values and metrics of Environmental, Social & Governance (ESG) criteria, Corporate Social Responsibility (CSR) and the United Nations Sustainable Development Goals (SDGs). This will allow ImpactWayv to provide advisory and support services through a global team of social impact sector leaders, experts and experienced professionals.

“Our current climate has demonstrated just how motivated people are to come together to foster positive social change,” said Benji Bernstein, Co-Founder and Chief Technology Officer of ImpactWayv, Inc. “The time is now for a new digital ecosystem that meets this critical moment – a social media network created to unite and empower people, businesses and nonprofits for greater collective impact, via a continuous cycle of social good. ImpactWayv is that platform, a breakthrough force for good.”

About ImpactWayv, Inc.

ImpactWayv, Inc. is a social impact media and technology company, consisting of thought leaders and doers from across the business, nonprofit and technology sectors. ImpactWayv was created to disrupt and transform the worlds of business and philanthropy through technology – to advance universal social good. For more information or to be added to the ImpactWayv user list, please visit: www.ImpactWayv.com .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release

Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye